Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering a web-based
Trxade Group Inc.
-(MEDS)
Get the latest Trxade Group Inc. (MEDS) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Trxade CEO Suren Ajjarapu: Will see the impact of GPO program by Q3 next year
Image: iStock Give us a quick overview of the company. Trxade is a market platform that caters to the independent pharmacies that
Traxde Health beats on Q3 revenue estimate
Trxade Health Inc (NASDAQ: MEDS) on Monday posted third-quarter revenues of $2.6 million, down year-over-over as a result of non-recurring PPE sales.
TRxADE HEALTH, Inc. (MEDS) Q3 2021 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q3 2021 earnings call dated Oct. 25, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary
It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025. In the
Trxade CEO: Will see consistent margins ahead
Shares of Trxade Health Inc (NASDAQ: MEDS) took a beating post the second-quarter results earlier this week as the provider of integrated
TRxADE HEALTH, Inc. (MEDS) Q2 2021 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2021 earnings call dated Jul. 26, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade Health adds 195 registered members in Q2
Trxade Health Inc (NASDAQ: MEDS) on Monday posted second-quarter revenues of $1.9 million, down year-over-over as a result of non-recurring PPE sales.
Trxade Health Inc. (NASDAQ: MEDS) Q2 2021 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), a health services IT company, plays a key role in ensuring the availability of healthcare services at
Trxade expects its health passport to be a key post-pandemic reopening tool
Over the past few months, Trxade Group (NASDAQ: MEDS) has been busy in its development lab, creating tools that could enable the
Trxade Group Inc. (MEDS) Q1 2021 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q1 2021 earnings call dated Apr. 26, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (MEDS) beats market expectations on Q1 revenue
Trxade (NASDAQ: MEDS) on Monday posted a 39% increase in first-quarter revenues to $3.1 million due to higher sales in the Integra
Trxade (MEDS) betting big on its new health passport app
With COVID-19 vaccination taking place on a full-fledged scale across the country, the Joe Biden administration had last month announced its commitment
Trxade Group, Inc. (MEDS) Q4 2020 Earnings Call Transcript
Trxade Group, Inc. (NASDAQ: MEDS) Q4 2020 earnings call dated Mar. 29, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade Group (MEDS) delivers annual revenue growth of 130%
Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of the Trxade
CEO TALKS: The story of Trxade Group (MEDS)
Probably the biggest highlight of Trxade Group Inc (NASDAQ: MEDS) is that it was set up to solve the problems faced by
Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $45 million Trxade Group Inc (NASDAQ: MEDS) has been serving pharmacies and drug manufacturers for
SingleCare deal aimed at growing subscribers: Trxade CEO Suren Ajjarapu
Trxade (NASDAQ: MEDS) may have been on a dream run of late due to the strong demand for PPE, but the drug
Trxade Group Inc. (MEDS) Q3 2020 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q3 2020 earnings call dated Oct. 26, 2020 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (MEDS) delivers another quarter of strong revenue growth
Trxade (NASDAQ: MEDS) on Monday posted a 174% increase in third-quarter revenues to $6.3 million, riding on continued strength in PPE sales.
Trxade Group Inc. (NASDAQ: MEDS) Q3 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $49 million Trxade Group (NASDAQ: MEDS) operates a web-based purchasing platform that brings together independent